UBS’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-230
Closed -$6K 11005
2014
Q2
$6K Sell
230
-490
-68% -$12.6K ﹤0.01% 9408
2014
Q1
$21K Sell
720
-960
-57% -$29.6K ﹤0.01% 8037
2013
Q4
$47K Sell
1,680
-1,390
-45% -$55.9K ﹤0.01% 7039
2013
Q3
$137K Buy
3,070
+2,080
+210% +$68.6K ﹤0.01% 5657
2013
Q2
$21K Buy
+990
New +$13.1K ﹤0.01% 7852

Other funds holding HQCL

UBS's HQCL Position: Q3 2014 in Review

UBS increased its Hanwha Q CELLS Co., Ltd. (HQCL) stake by 34% in Q3 2014, buying an estimated $7.88K and bringing the position to 1,354 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #7407.

UBS first reported a position in HQCL in Q2 2013 and has held it in 6 quarters since. The position peaked at $79K in Q1 2014. 33 funds tracked by Wall St. Rank hold HQCL as of Q3 2014.

  • UBS held 1,354 shares of Hanwha Q CELLS Co., Ltd. worth $32K as of Q3 2014.
  • UBS bought 342 Hanwha Q CELLS Co., Ltd. shares in Q3 2014, an estimated $7.88K.
  • Hanwha Q CELLS Co., Ltd. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7407 holding.
  • UBS first reported a position in Hanwha Q CELLS Co., Ltd. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Hanwha Q CELLS Co., Ltd. position peaked at $79K in Q1 2014.
  • 33 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.